Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 250-005-9 | CAS number: 30030-25-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 972
- Report date:
- 1972
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- GLP compliance:
- no
- Type of assay:
- other: cytogenicity study: bone marrow chromosome aberration
Test material
- Reference substance name:
- (chloromethyl)vinylbenzene
- EC Number:
- 250-005-9
- EC Name:
- (chloromethyl)vinylbenzene
- Cas Number:
- 30030-25-2
- Molecular formula:
- C9H9Cl
- IUPAC Name:
- 1-(chloromethyl)-3-ethenylbenzene; 1-(chloromethyl)-4-ethenylbenzene
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on species / strain selection:
- flow laboratories random-bred, closed colony, Sprangue-Dawley CD strain rats (ten to twelve weeks old, 280 - 350 g)
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Husbandry
Each animal room utilized in the study contained only one species. Rats were housed one to five to a cage as prescribed in each protocol. Animals were identified by ear punch. Sanitary cages and bedding were used, and changed two times per week, at which time water containers were cleaned, sanitized and filled. Once a week, cages were repositioned on racks; racks were repositioned within rooms monthly. Personnel handling animals or working with animal facilities wore head covering and face masks as well as suitable garments. Individuals with respiratory or other overt infections were excluded from the animal facilities.
Administration / exposure
- Route of administration:
- other: intubation or by mixing the compound in the feed
- Details on exposure:
- Preparation of Diet
A commercial 4%.fat diet was fed to all animals. Periodic tests to verify the absence of coliforms, Salmonella and Pseudomonas sp. were performed.
Dosage Determination
1. High Levels were prepared from information supplied by the sponsor.
2. The Usage Level was 1/10 of the Intermediate Level.
3. The Intermediate Level was 1/10 of the High Level.
4. Subacute Doses were identical to those used in the acute studies unless contraindicated.
C. Mutagenicity Testing Protocols 1. Cytogenetic Studies
Ten to twelve week old male, albino rats obtained from a closed colony (random-bred) were used, as illustrated in the following protocol:
Number of animals used
Subacute Study
Treatment Time Killed after Administration
48 hours 5 days
High Level 5
Medium Level 5
Low Level 5
Positive Control 5
Negative Control 3
Dosage: 1x/day x 5 days
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0.63 mg/kg bw/day (nominal)
- Remarks:
- Low dose level (dose contained in 1 mL)
The solvent employed was 0.5 % methylcellulose. The solution was prepared on a volume/volume basis.
- Dose / conc.:
- 6.3 mg/kg bw/day (nominal)
- Remarks:
- Medium dose level (dose contained in 1 mL)
The solvent employed was 0.5 % methylcellulose. The solution was prepared on a volume/volume basis.
- Dose / conc.:
- 63 mg/kg bw/day (nominal)
- Remarks:
- High dose level (dose contained in 1 mL)
The solvent employed was 0.5 % methylcellulose. The solution was prepared on a volume/volume basis.
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- triethylene melamine (dose 0.3 mg/kg bw/day contained in 1 mL)
The solvent employed was 0.5 % methylcellulose. The solution was prepared on a volume/volume basis.
Results and discussion
Any other information on results incl. tables
Cytogenetics
This compound produced no detectable significant aberrations of the bone marrow metaphase chromosomes of rats when administered orally at the dosage levels employed in this study.
Toxicity
No abnormal signs or pathology were noted in the animals used at the dose levels employed.
Test
Cytogenetics—The negative control group contained 2% breaks and the positive controls showed the expected severe damage. The intermediate and high (LD5) groups each contained 3% cells with breaks. This was not considered significant and is within historical negative control values.
Metaphase summary sheet
Compound | Dosage* (mg/kg) |
No. Of Animals |
No. of Cells |
Mitotic Index % | % Cells with Breaks |
% Cells with Reunions |
% Cells with more than 1 type of aber. | % Cells with Aber. | |
Negative control | methocel | 3 | 150 | 9 | 2 | 0 | 0 | 2 | |
Low level | 0.63 | 5 | 250 | 9 | 0 | 0 | 0 | 0 | |
Intermediate level | 6.3 | 5 | 250 | 6 | 3 | 0 | 0 | 0 | |
High level | 63 | 5 | 250 | 7 | 3 | 0 | 0 | 3 | |
Positive control (TEM**) | 0.3 | 5 | 250 | 3 | 28 | 9 | 3 | 39 | |
* Dosage 1x/day x 5 days | |||||||||
** TEM (Triethyl melamine) administered in an acute dose only one time. Animals killed 48 hours after administration of compound. |
Applicant's summary and conclusion
- Conclusions:
- The compound vinylbenzyl chloride produced no detectable significant aberrations of the bone marrow metaphase chromosomes of rats when administered orally at the dosage levels employed in this study (0, 0.63, 6.3, and 63 mg/kg bw/day administered for 5 consecutive days).
- Executive summary:
In a cytogenetics study in rats, doses of 0, 0.63, 6.3, and 63 mg/kg bw/day of vinylbenzyl chloride were orally administered on 5 consecutive days (5 animals per treatment group, 3 animals in the negative control group, 5 animals in the positive control group administered triethylene melamine). No abnormal signs or pathology were noted in the animals at the dose levels employed, and no detectable significant aberrations of the bone marrow metaphase chromosomes of rats were observed.
Cytogenetics of the bone marrow: The negative control group contained 2% breaks and the positive controls showed the expected severe damage. The intermediate and high dose groups each contained 3% cells with breaks. This was not considered significant and is within historical negative control values.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.